GLP-1 medications like Ozempic, Wegovy, and Mounjaro have transformed the way we treat type 2 diabetes and obesity—but what happens when pregnancy enters the picture?

In this episode of MamaDoc BabyDoc, we break down the growing use of GLP-1 receptor agonists and what patients (and providers) need to know about their safety before, during, and after pregnancy. We discuss how these medications work, their effects on ovulation and fertility, and why they are not recommended during pregnancy based on current evidence.

We also cover:

• When to stop GLP-1 medications if you're trying to conceive

• What to do if you become pregnant while taking one

• Potential risks to fetal development

• The role of weight management and metabolic health before pregnancy

• Safe alternatives for managing diabetes in pregnancy

As an OB/Gyn physician, I aim to give you clear, evidence-based guidance so you can make informed decisions for both mom and baby.

Whether you're a patient considering these medications or a provider counseling women of reproductive age, this episode offers practical, up-to-date insight on a rapidly evolving topic.

🎧 Tune in to MamaDoc BabyDoc for expert conversations on pregnancy, women's health, and everything in between.